![]() |
![]() |
|||||||||
|
The potential for less People with SBS who What some people
|
Zorbtive® [somatropin (rDNA origin) for injection] will not cure Short Bowel Syndrome, but… Through its action as growth hormone, and together with a special oral diet, Zorbtive may increase the ability of your small intestine to absorb nutrients and fluids. Absorbing more nutrients and fluids from what you eat and drink may reduce the need for parenteral nutrition (PN), and that is a very important treatment goal for SBS.
The potential for less PN dependence |
|||||||||
|
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed. Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling). Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications. This information is not intended to replace discussions with your healthcare professional. This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients This site contains medical information that is intended for residents of the United States © 2007 EMD Serono, Inc. All rights reserved.
|
||||||||||